Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction.
Belluomini L, Dionisi V, Palmerio S, Vincenzi S, Avancini A, Casali M, Riva ST, Menis J, Mazzarotto R, Pilotto S, Milella M. Belluomini L, et al. Among authors: dionisi v. Clin Lung Cancer. 2022 May;23(3):e269-e272. doi: 10.1016/j.cllc.2021.07.004. Epub 2021 Jul 20. Clin Lung Cancer. 2022. PMID: 34470722 Clinical Trial.
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort.
Borghetti P, Facheris G, Ciammella P, Galaverni M, Granello L, Scotti V, Franceschini D, Romei A, Giaj Levra N, Federico M, La Vecchia M, Merlotti A, Sepulcri M, Piperno G, Marvaso G, Simoni N, Alì E, Pontoriero A, Cappelli A, Dionisi V, Menis J, Martino A, Vagge S, Canova S, Montesi G, Cuccia F, Boldrini L, Franzese C, Grisanti S, Bruni A, Scorsetti M. Borghetti P, et al. Among authors: dionisi v. Clin Lung Cancer. 2024 Mar;25(2):151-158. doi: 10.1016/j.cllc.2023.11.005. Epub 2023 Nov 17. Clin Lung Cancer. 2024. PMID: 38052684
A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223.
Frantellizzi V, Monari F, Mascia M, Costa R, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Murabito A, Lavelli V, Nuvoli S, Cosma L, Dionisi V, Nappi AG, Andreola M, De Vincentis G. Frantellizzi V, et al. Among authors: dionisi v. Aging Clin Exp Res. 2021 Mar;33(3):651-658. doi: 10.1007/s40520-020-01573-5. Epub 2020 May 1. Aging Clin Exp Res. 2021. PMID: 32358729
Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter study.
Frantellizzi V, Monari F, Mascia M, Costa R, Rubini G, Spanu A, Di Rocco A, Lodi Rizzini E, Cindolo L, Licari M, Lavelli V, Nuvoli S, De Angelis C, Dionisi V, Ferrari C, De Vincentis G. Frantellizzi V, et al. Among authors: dionisi v. Ann Nucl Med. 2020 Oct;34(10):772-780. doi: 10.1007/s12149-020-01501-7. Epub 2020 Jul 11. Ann Nucl Med. 2020. PMID: 32654030 Free PMC article.
Radium-223 in mCPRC patients: a large real-life Italian multicenter study.
Frantellizzi V, Monari F, Mascia M, Costa RP, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Tripoli V, Lavelli V, Nuvoli S, Pontico M, Dionisi V, Ferrari C, DE Vincentis G. Frantellizzi V, et al. Among authors: dionisi v. Minerva Urol Nephrol. 2022 Feb;74(1):21-28. doi: 10.23736/S2724-6051.20.03808-4. Epub 2020 Aug 4. Minerva Urol Nephrol. 2022. PMID: 32748619 Free article.
Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study.
Frantellizzi V, Monari F, Mascia M, Costa R, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Licari M, Lavelli V, Nuvoli S, Ricci M, Dionisi V, Nappi AG, De Vincentis G. Frantellizzi V, et al. Among authors: dionisi v. Int J Radiat Biol. 2020 Dec;96(12):1608-1613. doi: 10.1080/09553002.2020.1838655. Epub 2020 Nov 3. Int J Radiat Biol. 2020. PMID: 33074066 Clinical Trial.